WHO top scientist lauds India's capacity to innovate, produce vaccines at Global Bio-India 2021
The three-day Global Bio-India 2021 was inaugurated Monday by Harsh Vardhan, the minister of Science & Technology, and Health & Family Welfare.

Soumya Swaminathan. Image Credit: Youtube
India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization's Chief Scientist Soumya Swaminathan said Monday. Speaking at the Global Bio-India 2021, she opined that the fight against the coronavirus
pandemic is at a very critical junction now as cases have suddenly gone up, particularly in Europe and America. There are many uncertainties now, especially on the different variants of the virus, she noted.
"India has shown the capacity to be a manufacturer at the global scale and also be an innovator when it came to vaccine development. There is a huge amount of scope to study the impact of vaccines, which needs to be thought-through by a very coordinated approach," she said.
As many as 30 vaccines are at different stages of development in India. Covaxin, developed indigenously by Bharat Biotech, and Covishield, developed by Oxford-AstraZeneca and being manufactured at Serum Institute of India, are already in use in the country.
The vaccine candidates of Zydus Cadila and Russia's Sputnik V are in phase 3 of the human clinical trials. Sputnik V, which is being manufactured by Reddy's Laboratories in India, has initiated the process for Emergency Use Authorisation (EUA) with the Drugs Controller General of India (DCGI).
India has supplied vaccines to several nations while many others have also placed orders for the same.
Vinod Paul, Member (Health), NITI Aayog lauded the efforts of scientific community and said the speed with which the solutions during the pandemic appeared was phenomenal.
The stories of development of vaccines are amazing examples of how time can be compressed and scientific mobilisation can be initiated. The intent to have a global footprint in the manufacturing sector when it came to COVID-19 vaccine was path-breaking and something to be proud of.
We have realised that we have the potential to deliver in a speedy manner, like we did for vaccine distribution, he said.
The three-day Global Bio-India 2021 was inaugurated Monday by Harsh Vardhan, the minister of Science & Technology, and Health & Family Welfare.
Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply
also read

South Korea administers first COVID-19 shots to people at long-term care facilities
The government has also decided to extend current social distancing levels for at least another two weeks.

'Premature, unrealistic' to think COVID-19 pandemic will end this year: WHO
Hospitalisations and deaths can be significantly reduced if the vaccine rollout is successful , said Michael Ryan, director of WHO's emergencies program

COVID-19 vaccine passports raise concerns about discrimination amin hope for an economic restart
If vaccines become a passport to doing things, we may see communities that have been already hardest hit by COVID being left behind.